Skip to content

Orthopedic Surgery

Economic Outcomes

Experience of a network of transfusion coordinators for blood conservation (Ontario Transfusion Coordinators [ONTraC]). (opens new window)

Freedman J, Luke K, Escobar M, Vernich L, Chiavetta JA.

Source‎: Transfusion 2008;48(2):237-50.

Indexed‎: PubMed 18005329

DOI‎: 10.1111/j.1537-2995.2007.01515.x

https://www.ncbi.nlm.nih.gov/pubmed/18005329 (opens new window)

Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. (opens new window)

Irisson E, Hémon Y, Pauly V, Parratte S, Argenson JN, Kerbaul F.

Source‎: Orthop Traumatol Surg Res 2012;98(5):477-83.

Indexed‎: PubMed 22854336

DOI‎: 10.1016/j.otsr.2012.05.002

https://www.ncbi.nlm.nih.gov/pubmed/22854336 (opens new window)

Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis. (opens new window)

Scardino M, Martorelli F, D'Amato T, Fenocchio G, Simili V, Grappiolo G, Di Matteo B, Kon E, Lagioia M

Source‎: Int Orthop 2019;43(12):2707-14.

Indexed‎: PubMed 30671601

DOI‎: 10.1007/s00264-019-04291-4

https://www.ncbi.nlm.nih.gov/pubmed/30671601 (opens new window)

Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. (opens new window)

Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE.

Source‎: J Arthroplasty 2014;29(8):1512-5.

Indexed‎: PubMed 24630599

DOI‎: 10.1016/j.arth.2014.01.031

https://www.ncbi.nlm.nih.gov/pubmed/24630599 (opens new window)